AN2 THERAPEUTICS INC's ticker is and the CUSIP is 037326105. A total of 37 filers reported holding AN2 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,442,588 | +220.4% | 89,691 | +69.3% | 0.00% | – |
Q2 2023 | $450,177 | -68.5% | 52,962 | -63.5% | 0.00% | – |
Q1 2023 | $1,430,626 | +121863.0% | 144,947 | +17.8% | 0.00% | – |
Q4 2022 | $1,173 | -99.9% | 123,085 | +47.8% | 0.00% | – |
Q3 2022 | $1,447,000 | +144.4% | 83,291 | +8.9% | 0.00% | – |
Q2 2022 | $592,000 | – | 76,467 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Monashee Investment Management LLC | 433,330 | $6,530,000 | 1.89% |
RA Capital Management | 3,666,663 | $55,257,000 | 1.21% |
BVF INC/IL | 1,616,665 | $24,363,000 | 0.98% |
Avidity Partners Management LP | 688,330 | $10,373,000 | 0.22% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 584,136 | $8,803,000 | 0.20% |
COWEN AND COMPANY, LLC | 60,278 | $908,000 | 0.09% |
Woodline Partners LP | 150,000 | $2,261,000 | 0.04% |
Alyeska Investment Group, L.P. | 125,000 | $1,884,000 | 0.02% |
Citadel Advisors | 1,419,851 | $20,593,000 | 0.00% |
Anson Funds Management LP | 2,500 | $38,000 | 0.00% |